In the US this year, ~2.7K men are expected to be diagnosed with breast cancer and ~530 may die, highlighting high-quality care's importance.
New US findings linked private insurance with earlier-stage diagnosis, quicker treatment starts, and longer survival for men with breast cancer, spotlighting access as a priority.
Men without coverage were less likely to be diagnosed early and more likely to face treatment delays over time, even though nearly all received care.
The findings also tied race and ethnicity, neighborhood poverty, and facility type to differences in diagnosis, treatment timing, and survival across the US.
Researchers said expanding access and reducing barriers to timely, high-quality care could improve outcomes, while more male-specific research may strengthen treatment guidance in the US.
